Yahoo
Tokyo - Delayed Quote JPY

Kaneka Corporation (4118.T)

6,206.00 +73.00 (+1.19%)
At close: 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 4118.T
  • Previous Close 6,133.00
  • Open 6,180.00
  • Bid --
  • Ask --
  • Day's Range 6,171.00 - 6,221.00
  • 52 Week Range 4,113.00 - 6,570.00
  • Volume 240,700
  • Avg. Volume 225,723
  • Market Cap (intraday) 371.457B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 10.70
  • EPS (TTM) 579.84
  • Earnings Date Nov 11, 2026
  • Forward Dividend & Yield 210.00 (3.42%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est 5,541.67

Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan, Asia, North America, Europe, and internationally. It offers impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymer, engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. The company was incorporated in 1949 and is headquartered in Tokyo, Japan.

www.kaneka.co.jp

11,762

Full Time Employees

March 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4118.T
46.09%
Nikkei 225 (^N225)
27.05%

1-Year Return

4118.T
50.62%
Nikkei 225 (^N225)
27.35%

3-Year Return

4118.T
82.98%
Nikkei 225 (^N225)
106.36%

5-Year Return

4118.T
67.45%
Nikkei 225 (^N225)
121.91%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 213.36B
Earnings 12.54B
Profit Margin 5.88%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
50B
100B
150B
200B
3.0%
4.0%
5.0%

Analyst Insights

View More

Analyst Price Targets

4,550.00 Low
5,541.67 Average
6,206.00 Current
6,300.00

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 10/26/2026
  • Market Cap

    363.26B

  • Enterprise Value

    560.53B

  • Trailing P/E

    10.47

  • Forward P/E

    --

  • PEG Ratio (current)

    1.01

  • Price/Sales (ttm)

    0.45

  • Price/Book (mrq)

    0.72

  • Enterprise Value/Revenue

    0.67

  • Enterprise Value/EBITDA

    5.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.26%

  • Return on Assets (ttm)

    2.52%

  • Return on Equity (ttm)

    7.36%

  • Revenue (ttm)

    835.98B

  • Net Income Avi to Common (ttm)

    35.66B

  • Diluted EPS (ttm)

    579.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    52.58B

  • Total Debt/Equity (mrq)

    43.03%

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: